RE:FYI - updated corp presentation dated Sept 2021 Accelerated Approval option not shown, as that would depend on data at 450days on 25 patients, plus the interim data on patients 26 and on. iMO I'm guessing about 12 -18months after BTD, so possibly late 2022 until mid 2023 if that option becomes available on impressive data. ( very possible if optimized treatments continue to show high and durable efficacy). All IMHO but looking very good. Mention of commercialisation with big Pharma, which means probably some collaboration with Big Pharma before hand and maybe with other indications. Leading up to eventual BO.
DJDawg wrote:
Hi all. Hope you are having a good weekend.
You may have noticed, corp presentation updated recently.
https://theralase.com/wp-content/uploads/2021/08/Corporate-PPT-09213.pdf
Some cleaner presenation slides on some of the topics. Nicer slides updating the hope around GBM and NSCLC treatment.
Interesting, the timelines on slide 13, show some hope that BTD might be achieved in window of late late 2021 till mid 2022.